These findings suggest that larger subcutaneous and visceral adipocyte sizes are associated with lower adiponectin mRNA expression in individuals with obesity but lower serum adiponectin levels in individuals without obesity. The gene discussed is ADIPOQ; the disease is obesity disorder.